Retatrutide vs Tirzepatide: Comparing Triple and Dual Receptor Agonism

For laboratory research and qualified professionals only.

Retatrutide and tirzepatide are two of the most studied peptides in metabolic research. In this article, we compare their receptor pharmacology based on available laboratory data.

Receptor Specificity

Retatrutide activates three receptors (GIP, GLP-1, and glucagon), while tirzepatide works as a dual GIP/GLP-1 agonist. This difference in receptor profile leads to notable differences in experimental models.

Metabolic Models

In studies on adipocytes and hepatocytes, retatrutide demonstrates more pronounced effects on energy expenditure and lipolysis compared to the dual agonist. Laboratory data continue to refine these differences.

Phase 3 Data

Publicly available data from clinical trial registries provide researchers with important pharmacokinetic parameters for planning precise in-vitro experiments.

For laboratory research only.

→ Retatrutide Research Peptide
→ Tirzepatide Research Peptide
→ Retatrutide vs Tirzepatide Comparison

Author: Dr. Elena Voss, PhD Biochemistry – Senior Research Scientist, PenLab Peptide Research Division